Health

Ensysce Biosciences, Inc. Announces Chief Medical Officer Changes

Ensysce Biosciences, Inc. has announced that it has accepted the resignation proposal of its Chief Medical Officer, Dr. Nily Osman, has received such resignation as of September 15, 2022. The company has appointed Dr. William K. Schmidt, Ph. D. as the Company’s interim Chief Medical Officer, effective September 15, 2022. Dr. Schmidt, who also serves as the company’s senior vice president of clinical development.

dr. Schmidt, aged 72, was Ensysce’s Chief Medical Officer from January 1, 2016 to April 18, 2022. Between April 18, 2022 and September 15, 2022, he was the company’s Senior Vice President of Clinical Development. He is also the head of NorthStar Consulting, the parliamentarian and a past president of the Eastern Pain Association, the largest regional affiliate of the American Pain Society.

Read:The Hidden Pain of Pediatric Medical Traumatic Stress

He has over 25 years of experience in the pharmaceutical industry with a special emphasis on the discovery and development of novel analgesic and narcotic antagonists. He previously served as Vice President of Clinical Development for CrystalGenomics (Seoul, South Korea) and its US subsidiary, CG Pharmaceuticals (Emeryville, CA); Senior Vice President of Development at Limerick BioPharma; Vice President, Clinical Research, for Renovis, Inc.; and Vice President, Scientific Affairs and Acting Vice President, Clinical Research and Development, at Adolor Corporation. At Adolor Corporation, Dr. Schmidt was a key member of the team leading to the clinical development, NDA filing and FDA approval of Entereg® (alvimopan), a peripherally acting opioid antagonist.

Currently Dr. Schmidt is an expert in pharmaceutical development of pain medication at pharmaceutical and biotech companies in North America, Europe, Asia, Latin America and Australia. dr. Schmidt received a Bachelor of Arts degree from the University of California Berkeley and his Ph.D. University of California-San Francisco.

Read:Toyota Tsusho : to Establish Medical Treatment-Related Service Joint Venture- Providing Safe, Dependable Japanese-Style Services such as Linen Services in India –

Previous post
Tech Co. Ready To Advance in New Bull Market
Next post
King Charles’ visit on Owain Glyndŵr day is ‘insensitive to the point of insulting’ says Michael Sheen